Epoetin beta biosimilar (Microgen)

促红素β生物类似药 (Microgen)

Report date: 2022/01/14 13:23:58

Base Information

Drug NameEpoetin beta biosimilar (Microgen)
Drug Alias Name依泊汀β生物仿制药 (CinnaGen)Epoetin beta follow-on biologic促红素β生物仿制药 (Microgen)倍他依泊汀生物仿制药 (CinnaGen)Erythrostim
ClassificationBiologics > BiosimilarBiologics > Protein drugs > Recombinant protein > Recombinant cytokines
Mechanisms of ActionErythropoiesis stimulantsErythropoietin receptor agonists
TargetsErythropoietin receptor
Therapy Area/IndicationsAnemia
Global Approved IndicationsAnemia
Approved Indications in ChinaN/A
Original Approved Country/TerritoryRussian Federation
Original Approved Date2012/01/01
Country/TerritoryRussian Federation
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaN/A
Originator CompaniesMicrogen State Scientific Industrial
China Registration ClassN/A

Develop Information

Active CompaniesMicrogen State Scientific Industrial
Inactive CompaniesN/A
Active IndicationsAnemia
Inactive IndicationsN/A

Other Information

ATC CodeB03XA01
Related LinksN/A